June 18 (Reuters) – The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.
Headlines
CureVac to press on with mRNA vaccine despite disappointing trials https://on.ft.com/3iPDppZ
Channel 4 lined up for privatisation as early as 2022 https://on.ft.com/3vKsSiR
Sunak refuses help for businesses hit by extended COVID-19 restrictions https://on.ft.com/2SyBCel
Ebay to sell South Korea unit for $3.1bn as local rivals target Coupang https://on.ft.com/3qhsx69
Overview
German drug maker CureVac NV’s CEO still believes that its coronavirus vaccine could still be used for some age groups or as a booster despite disappointing results from trials.
Public broadcaster Channel 4 will move towards privatisation as soon as next year by the UK government with ministers launching formal consultation within a few weeks.
Rishi Sunak refuses any further extension of support to businesses in England despite government orders to close for four more weeks due to rise in coronavirus cases.
Ebay Inc is set to sell its South Korea business to a local consortium for $3.1 billion, according to people with knowledge of the matter, as rivals seek to turn up the heat on SoftBank-backed Coupang Inc. (Compiled by Bengaluru newsroom)
